Details of the Drug

General Information of Drug (ID: DMB9QSJ)

Drug Name
CRx-191
Indication
Disease Entry ICD 11 Status REF
Psoriatic disorder EA90 Discontinued in Phase 2 [1]
Cross-matching ID
TTD ID
D0VA2I

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interferon-gamma (IFNG) TT93WF5 IFNG_HUMAN Inhibitor [2]
Tumor necrosis factor (TNF) TTF8CQI TNFA_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025635)
2 CombinatoRx Drug Candidate CRx-191 Demonstrates Positive Phase 2 Results In Psoriasis. CombinatoRx. 2008.